company background image
EVH logo

Evolent Health NYSE:EVH Voorraadrapport

Laatste prijs

US$13.36

Marktkapitalisatie

US$2.8b

7D

-43.1%

1Y

-52.3%

Bijgewerkt

08 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Evolent Health, Inc.

NYSE:EVH Voorraadrapport

Marktkapitalisatie: US$2.8b

EVH Overzicht aandelen

Evolent Health, Inc. biedt via haar dochteronderneming Evolent Health LLC gespecialiseerde zorgmanagementdiensten aan in de oncologie, cardiologie en musculoskeletale markten in de Verenigde Staten.

Evolent Health, Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Evolent Health
Historische aandelenkoersen
Huidige aandelenkoersUS$13.36
52 Week HoogtepuntUS$35.00
52 Week LaagUS$13.31
Bèta1.59
11 maand verandering-49.14%
3 maanden verandering-49.39%
1 Jaar Verandering-52.29%
33 jaar verandering-53.02%
5 jaar verandering40.63%
Verandering sinds IPO-29.16%

Recent nieuws en updates

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Recent updates

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

Rendement voor aandeelhouders

EVHUS Healthcare ServicesUS Markt
7D-43.1%5.7%5.1%
1Y-52.3%20.3%37.7%

Rendement versus industrie: EVH presteerde slechter dan de US Healthcare Services -sector, die het afgelopen jaar een rendement van 20.3 % opleverde.

Rendement versus markt: EVH presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 37.7 % opleverde.

Prijsvolatiliteit

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement16.2%
Healthcare Services Industry Average Movement9.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: De aandelenkoers van EVH is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van EVH is het afgelopen jaar gestegen van 10% naar 16%.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
20114,700Seth Blackleywww.evolent.com

Evolent Health, Inc. biedt via haar dochteronderneming Evolent Health LLC gespecialiseerde zorgmanagementdiensten aan in de oncologie, cardiologie en musculoskeletale markten in de Verenigde Staten. Het bedrijf biedt een platform voor de administratie van gezondheidsplannen en op waarde gebaseerde bedrijfsinfrastructuur. Het biedt administratieve diensten, zoals health plan services, pharmacy benefits management, risk management, analytics en rapportage, en leiderschap en management; en Identifi, een eigen technologisch systeem dat gegevens verzamelt en analyseert, zorgworkflows beheert en patiënten betrekt.

Evolent Health, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Evolent Health zich tot de beurswaarde?
EVH fundamentele statistieken
MarktkapitalisatieUS$2.83b
Inkomsten(TTM)-US$104.23m
Inkomsten(TTM)US$2.46b

0.6x

P/S-verhouding

-14.7x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EVH resultatenrekening (TTM)
InkomstenUS$2.46b
Kosten van inkomstenUS$2.07b
BrutowinstUS$393.27m
Overige uitgavenUS$497.50m
Inkomsten-US$104.23m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-0.91
Brutomarge15.96%
Nettowinstmarge-4.23%
Schuld/Eigen Vermogen Verhouding48.9%

Hoe presteerde EVH op de lange termijn?

Bekijk historische prestaties en vergelijking